Alpha JWC Ventures Leads Funding Round for Bumame to Advance Digital Healthcare

Indonesia-based healthtech startup Bumame has secured pre-Series A funding in a round led by Alpha JWC Ventures, with participation from 500 Global and Kopital Ventures. While the exact amount remains undisclosed, the investment will support Bumame’s efforts to enhance its digital capabilities and expand its range of healthcare services.

With this funding, Bumame will be focusing on early detection, fast and accurate diagnostics, and personalized health insights. The company seeks to promote proactive and preventive care, empowering individuals to take greater control of their well-being.

Bumame, founded in 2020, initially gained recognition for providing widespread COVID-19 testing services across Indonesia. Leveraging the trust it built during the pandemic, the company has since expanded its focus to address broader healthcare challenges through innovation and technology. Today, Bumame offers a wide range of services, including advanced diagnostics, proactive health screenings, and personalized health plans.

The fresh funding will accelerate Bumame’s digital transformation and enhance its service offerings. By leveraging technology-driven solutions, the company aims to provide seamless and efficient healthcare experiences. With a strong emphasis on early detection and accurate diagnostics, Bumame is committed to empowering individuals with the insights they need to make informed health decisions.

Indonesia’s healthcare market, valued at approximately $50 billion in 2024, is experiencing rapid growth, with an annual increase of 11%. This rising demand for modern and accessible healthcare solutions presents a significant opportunity for companies like Bumame to redefine affordability and accessibility in the industry.

James Wihardja, Co-Founder and CEO of Bumame emphasized the company’s mission to go beyond traditional healthcare services. “We are not just a provider; we strive to be a lifelong health partner for every individual in Indonesia. Our goal is to build a healthier, more confident society through proactive and preventive care,” he said.

Chandra Tjan, Co-Founder and General Partner at Alpha JWC Ventures highlighted the strong investor confidence in Bumame’s vision. He noted, “By prioritizing technology, proactive care, and high-quality products sourced from top principals with global standards, Bumame ensures that healthcare is not only accessible but also affordable for all Indonesians.”

Alpha JWC Ventures, a prominent early-to-growth-stage venture capital firm in Southeast Asia, led the funding round. Established in 2016, it is Indonesia’s first independent and institutional early-stage VC fund. With approximately $650 million in assets under management (AUM) and over 80 active portfolio companies, Alpha JWC has built a strong presence in the region, supporting startups with capital and strategic guidance.

Other investors in the round include 500 Global, a multi-stage investment firm managing $2.2 billion in AUM, and Kopital Ventures, an early-stage, sector-agnostic VC firm focused on Indonesia. Since its launch in September 2023, Kopital Ventures has invested in nearly 20 companies and plans to expand its portfolio to 60 in the coming years. The participation of these leading investors underscores strong confidence in Bumame’s mission and growth potential.